KIMBERLY WALSH: Open Payments
NPI 1609479070 · STAMFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$288 in 18 payments from 2 companies in 2025. Trend: 2023 $288 · 2024 $426 · 2025 $288
Food & beverage: $288
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 16 | $241 |
| Optinose US, Inc. | 2 | $46 |
Products named: NUCALA, Xhance.
Industry payments across CT — which companies pay providers there.
